OCWP
PFE icon

Owl Creek Wealth Partners’s Pfizer PFE Stock Holding History

Owl Creek Wealth Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$102K Sell
4,246
-435
-9% -$11.4K 0.03% 192
2026
Q1 		$131K Buy
+4,681
New +$125K 0.05% 138

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Owl Creek Wealth Partners's PFE Position: Q2 2026 in Review

Owl Creek Wealth Partners reduced its Pfizer (PFE) stake by 9.3% in Q2 2026, selling an estimated $11.4K and leaving 4,246 shares worth $102K. The position accounts for 0.03% of the portfolio, ranked #192.

Owl Creek Wealth Partners first reported a position in PFE in Q1 2026 and has held it in 2 quarters since. The position peaked at $131K in Q1 2026. 2,713 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Owl Creek Wealth Partners held 4,246 shares of Pfizer worth $102K as of Q2 2026.
  • Owl Creek Wealth Partners sold 435 Pfizer shares in Q2 2026, an estimated $11.4K.
  • Pfizer made up 0.03% of Owl Creek Wealth Partners's portfolio in Q2 2026, its #192 holding.
  • Owl Creek Wealth Partners first reported a position in Pfizer in Q1 2026 and has held it in 2 quarters since.
  • Owl Creek Wealth Partners's Pfizer position peaked at $131K in Q1 2026.
  • 2,713 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Owl Creek Wealth Partners's 13F filing for Q2 2026, filed 20 Jul 2026.